Alvotech (ICE: ALVO)
1,715.00
+40.00 (2.39%)
Jul 2, 2024, 3:18 PM GMT
Alvotech Revenue
Alvotech had revenue of $114.39M USD in the twelve months ending March 31, 2024, with 14.27% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $36.89M USD with 132.29% year-over-year growth. In the year 2023, Alvotech had annual revenue of $93.38M USD with 9.84% growth.
Revenue (ttm)
$114.39M
Revenue Growth
+14.27%
P/S Ratio
n/a
Revenue / Employee
$114,508
Employees
999
Market Cap
513.72B ISK
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 93.38M | 8.37M | 9.84% |
Dec 31, 2022 | 85.02M | 45.33M | 114.23% |
Dec 31, 2021 | 39.68M | -29.77M | -42.86% |
Dec 31, 2020 | 69.45M | -13.23M | -16.00% |
Dec 31, 2019 | 82.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Marel hf. | 252.73B |
Íslandsbanki hf. | 62.05B |
Arion banki hf. | 60.06B |
Sildarvinnslan Hf. | 49.13B |
Brim hf. | 62.68B |
Hagar hf | 175.85B |
Hampiðjan hf. | 48.98B |
Kvika banki hf. | 14.14B |
Alvotech News
- 1 day ago - Alvotech Issues New Shares to Holders of Convertible Bonds - GlobeNewsWire
- 2 days ago - Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the Second Quarter of 2024 - GlobeNewsWire
- 2 days ago - Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the Second Quarter of 2024 - GlobeNewsWire
- 7 days ago - Alvotech Receives Conversion Notices for Majority of Convertible Bonds - GlobeNewsWire
- 7 days ago - Alvotech Receives Conversion Notices for Majority of Convertible Bonds - GlobeNewsWire
- 15 days ago - Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe - GlobeNewsWire
- 22 days ago - Alvotech and STADA add to Strategic Alliance through Denosumab Partnership - GlobeNewsWire
- 22 days ago - Alvotech and STADA add to strategic alliance through denosumab partnership - GlobeNewsWire